NasdaqGS - Delayed Quote
USD
Regeneron Pharmaceuticals, Inc. (REGN)
827.72
-15.75
(-1.87%)
At close: September 4 at 4:00:00 PM EDT
845.04
+17.32
(+2.09%)
After hours: September 4 at 7:42:48 PM EDT
Trade REGN on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutRegeneron Pharmaceuticals (REGN) recently received FDA approval for its rare disease drug Pasatru, enhancing its product pipeline. Despite this, the stock faces mixed performance metrics and competitive pressures, particularly in its established therapies like Eylea.
